We Can Medicines Balance Sheet Health
Financial Health criteria checks 4/6
We Can Medicines has a total shareholder equity of NT$1.2B and total debt of NT$141.3M, which brings its debt-to-equity ratio to 12.3%. Its total assets and total liabilities are NT$3.2B and NT$2.0B respectively. We Can Medicines's EBIT is NT$7.1M making its interest coverage ratio 0.3. It has cash and short-term investments of NT$296.6M.
Key information
12.3%
Debt to equity ratio
NT$141.29m
Debt
| Interest coverage ratio | 0.3x |
| Cash | NT$296.64m |
| Equity | NT$1.15b |
| Total liabilities | NT$2.03b |
| Total assets | NT$3.19b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6929's short term assets (NT$1.5B) exceed its short term liabilities (NT$957.3M).
Long Term Liabilities: 6929's short term assets (NT$1.5B) exceed its long term liabilities (NT$1.1B).
Debt to Equity History and Analysis
Debt Level: 6929 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 6929's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 6929's debt is well covered by operating cash flow (96.8%).
Interest Coverage: 6929's interest payments on its debt are not well covered by EBIT (0.3x coverage).